Skip to main content
Clinical Trials/JPRN-UMIN000035976
JPRN-UMIN000035976Recruiting未知

Clinical study to evaluate the usefulness of 18F-FBPA-PET for patient selection and expanding indication for BNCT - Usefulness of 18F-FBPA-PET

Southern TOHOKU BNCT Research Center0 sites20 target enrollmentStarted: February 22, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.To provide therapy evaluation 2.Patients with significant complications poorly controlled glycaemia poorly controlled hyperpiesia obstructive pulmonary disease kidney disease(chronic kidney failure, acute kidney injur, Nephrotic syndrome, diseases requiring dialysis) heart disease with symptomatic heart failure 3.Patients with phenylketonuria 4.Patients who were enrolled in this clinical study or BNCT related study within 3 months after the initial informed consent or who are participating and will participate in other clinical study 5.Patients who are pregnancy and want to become pregnant and male patients who want partner to become pregnant 6.Patients with complications of mental disease or psychological symptom can't be participated in this clinical study or are taking antipsychotics 7.Patients with poorly controlled epilepsy 8.Patients whom an attending physician determined ineligible

Investigators

Sponsor
Southern TOHOKU BNCT Research Center

Similar Trials